iCoreConnect, Inc. is a market leading, cloud-based software and technology company focused on increasing workflow productivity and customer profitability through its enterprise and healthcare workflow platform of applications and services. iCoreConnect is most notably known for its innovation in solving healthcare business problems. iCoreConnect’s philosophy places a high value on customer feedback, allowing iCoreConnect to respond to the market’s needs. iCoreConnect touts 15 SaaS enterprise solutions and more than 90 agreements with state or regional healthcare associations across the United States
Company profile
Ticker
ICNP, ICCRW
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
iMedicor, Vemics, Inc.
SEC CIK
Corporate docs
IRS number
134182867
Latest filings (excl ownership)
15-12G
Securities registration termination
28 Aug 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
28 Jul 23
DEFM14A
Proxy related to merger
12 Jul 23
10-Q
2023 Q1
Quarterly report
16 Jun 23
10-K/A
2022 FY
Annual report (amended)
16 Jun 23
8-K
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
25 May 23
8-K
Other Events
19 May 23
NT 10-Q
Notice of late quarterly filing
15 May 23
Latest ownership filings
4
Kevin Patrick McDermott
27 Jul 23
4
Joseph Gitto
27 Jul 23
4
Harry Joseph Travis
27 Jul 23
4
Robert P McDermott
27 Jul 23
4/A
Jeff Wayne Stellinga
27 Jul 23
4
David A. Fidanza
26 Jul 23
4
Jeff Wayne Stellinga
26 Jul 23
4
Muralidar Chakravarthi
26 Jul 23
4
Archit Shah
26 Jul 23
3
John Pasqual
24 Apr 23
Financial summary
Quarter (USD) | Jun 23 | Mar 23 | Dec 22 | Sep 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 68.74 k | 68.74 k | 68.74 k | 68.74 k | 68.74 k | 68.74 k |
Cash burn (monthly) | 244.89 k | 7.96 k | 702.86 k | 504.44 k | 255.81 k | 146.47 k |
Cash used (since last report) | 3.65 mm | 118.64 k | 10.48 mm | 7.52 mm | 3.81 mm | 2.18 mm |
Cash remaining | -3.58 mm | -49.91 k | -10.41 mm | -7.45 mm | -3.74 mm | -2.11 mm |
Runway (months of cash) | -14.6 | -6.3 | -14.8 | -14.8 | -14.6 | -14.4 |
Institutional ownership, Q3 2019
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Jul 23 | Joseph Gitto | Common Stock | Grant | Acquire A | No | No | 0 | 97,983 | 0.00 | 97,983 |
1 Jul 23 | Harry Joseph Travis | Common Stock | Grant | Acquire A | No | No | 0 | 262,506 | 0.00 | 450,006 |
14 Apr 23 | Chakravarthi Muralidar | Common Stock | Grant | Acquire A | No | No | 0 | 100,000 | 0.00 | 1,093,753 |